USD $675.00
PROMACTA, also known as REVOLADE in some regions, is a medication designed to help increase platelet levels in the blood. It is primarily used for patients with certain medical conditions that cause low platelet counts, such as chronic immune thrombocytopenia (ITP), severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C.
PROMACTA, REVOLADE functions by stimulating the bone marrow to produce more platelets. This is achieved through its action as a thrombopoietin receptor agonist, which helps to enhance the body's natural platelet production process, thereby reducing the risk of bleeding associated with low platelet counts.
This medication is beneficial for individuals diagnosed with chronic immune thrombocytopenia (ITP) who have not responded well to other treatments. It is also used in patients with severe aplastic anemia who have not responded to immunosuppressive therapy and those with thrombocytopenia due to chronic hepatitis C, to allow for the initiation and maintenance of interferon-based therapy.
Before starting PROMACTA, REVOLADE, it is important for patients to discuss their full medical history with their healthcare provider. This includes any pre-existing conditions, allergies, or other medications they are currently taking. Regular monitoring of liver function and platelet counts is necessary while on this medication to ensure its effectiveness and to adjust dosages as needed.
Like all medications, PROMACTA, REVOLADE may cause side effects. Common side effects include nausea, fatigue, and headaches. More serious side effects can occur and should be reported to a healthcare provider immediately, such as liver problems, blood clots, and cataracts. It is essential to follow the prescribed dosage and attend all scheduled medical appointments for monitoring.
PROMACTA, REVOLADE is available in tablet form and should be taken orally as directed by a healthcare provider. The specific dosage and administration guidelines depend on the patient's medical condition and response to treatment. It is important to follow the healthcare provider's instructions carefully and not to alter the dosage without prior consultation.
For more detailed information about PROMACTA, REVOLADE, including clinical studies, patient support, and detailed usage guidelines, patients should consult their healthcare provider or visit the manufacturer's official website. Additional resources may be available through patient advocacy groups and medical literature.
Health Guides